tiprankstipranks
GlaxoSmithKline (GSK)
NYSE:GSK
US Market
GSK
GlaxoSmithKline
RESEARCH TOOLSreports

GlaxoSmithKline (GSK) Stock News & Sentiment

5,219 Followers
GSK’s New Cancer Drug GSK5533524 Enters First‑in‑Human Testing: What Investors Should Watch
Premium
Company Announcements
GSK’s New Cancer Drug GSK5533524 Enters First‑in‑Human Testing: What Investors Should Watch
6d ago
GSK
GSK’s New Efimosfermin Alfa Trial Signals Renewed Push Into Fatty Liver Disease
Premium
Company Announcements
GSK’s New Efimosfermin Alfa Trial Signals Renewed Push Into Fatty Liver Disease
16d ago
GSK
M&A News: Gilead Bets $2B+ on Ouro Medicines to Power Immunology Growth
Premium
Market News
M&A News: Gilead Bets $2B+ on Ouro Medicines to Power Immunology Growth
20d ago
GSK
GILD
GSK Advances New Phase 3 Trial in Hard-to-Treat Ovarian Cancer: What Investors Should Watch
Premium
Company Announcements
GSK Advances New Phase 3 Trial in Hard-to-Treat Ovarian Cancer: What Investors Should Watch
24d ago
GSK
GSK Wins First U.S. Approval for Lynavoy in PBC-Related Itch, Advancing Hepatology Push
Premium
Company Announcements
GSK Wins First U.S. Approval for Lynavoy in PBC-Related Itch, Advancing Hepatology Push
24d ago
6K
GSK
GSK Discloses Chief People Officer’s March 16 ADS Purchase Under Pension Plan
Premium
Company Announcements
GSK Discloses Chief People Officer’s March 16 ADS Purchase Under Pension Plan
25d ago
6K
GSK
GSK Expands March Buyback With 732,112-Share Repurchase
Premium
Company Announcements
GSK Expands March Buyback With 732,112-Share Repurchase
25d ago
6K
GSK
More GSK News >

GSK News on the Web

Why GSK (GSK) is a Top Momentum Stock for the Long-Term
Zacks
Bullish
UBS Remains a Hold on GlaxoSmithKline (GSK)
TipRanks News
Neutral
GSK Withdraws Approval for Wellcovorin Drug Amid Market Changes
GuruFocus News
Bearish
GSK pulls application for leucovorin calcium, WSJ reports
TipRanks News
Neutral
GSK announces China’s NMPA approved Exdensur as add-on therapy
TipRanks News
Neutral
GSK Announces Approval Of Exdensur In China
rttnews
Bullish
GSK (GSK) is a Top-Ranked Value Stock: Should You Buy?
Zacks
Bullish
J.P. Morgan Keeps Their Sell Rating on GlaxoSmithKline (GSK)
TipRanks News
Bearish

News Score - Last 7 Days

Neutral
GSK
Sector Average
Media Buzz
This Week11 articles
Weekly Average14 articles
News Sentiment
This Week57%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GSK’s Media Buzz Sentiment?
11 articles about GSK were published this week. In an average week, 14 articles are published.
    What is GSK’s weekly average amount of articles?
    In an average week, 14 articles about GSK are published.
      What is GSK’s News Sentiment?
      57% of articles about GSK were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        NBIXNeurocrine
        STAAStaar Surgical
        SLPSimulations Plus
        OWLTOwlet
        Showing the stocks with the most bullish news sentiment over the past week